Speyside 2023 Emerging Markets Healthcare Outlook - Jan23 - VF
Speyside 2023 Emerging Markets Healthcare Outlook - Jan23 - VF
Speyside 2023 Emerging Markets Healthcare Outlook - Jan23 - VF
Trends in Emerging
Markets:
A Look Ahead
Executive Summary 03
The challenge of healthcare affordability amid increasing healthcare costs 04
The shift towards prevention focused healthcare systems 06
Case Study: Healthier Singapore 07
Case Study: Self-care in Latin America 08
Market access in the context of regulatory harmonization and reliance 09
Impactful collaboration to contribute to enhanced innovation capacity across the globe 10
Case study: Improving market access by making patents registration processes more
efficient in Brazil 11
Lasting changes in healthcare dynamics and patients after the pandemic 12
Integration of AI, technology, and data analysis for healthcare decisions 13
Case Study: AI Applications in Diabetes 14
Case Study: A mobile app that improves last-mile medical logistics in Nigeria 15
Climate Change & Healthcare 16
The need for innovative and integrated healthcare solutions 17
Speyside Group, a global emerging markets corporate affairs and public policy specialist, has analyzed the
landscape for healthcare in emerging markets and identified some trends that will shape healthcare systems in the
near term. This report contains a brief analysis of the main trends and opportunities that 2023 will bring in the
following areas:
THE CHALLENGE makes governments ask themselves increasingly how to achieve access
to innovative therapies while still meeting the existing healthcare costs
and ongoing demands of its population. Value-based contracting will
AFFORDABILITY
increasing healthcare costs. Understanding local drivers and gaps in the
capacity to implement innovative agreements, such as data gaps or local
human capital.will be vital in 2023.
AMID INCREASING
HEALTHCARE
COSTS
As the world economy slows down, healthcare costs are rising at an
alarming rate. This is a major concern for healthcare systems around
the world, as they grapple with the challenge of how to provide quality
care while containing costs. In developed economies, healthcare costs
are rising at a time when government budgets are under strain. This is
also true in many emerging markets, where health systems are often
underfunded and lack the capacity to cope with rising costs.
On the occasion of the 75th WHO World Health Assembly, the Global Self-
Care Federation (GSCF) launched the Global Social and Economic Value of
Self-Care study on a ceremony in Geneva, Switzerland. Some of the highlights
of the research conducted in eighteen countries across four continents showed
that self-care can lead to savings of nearly USD 120 billion each year for global
healthcare systems.
However, emerging markets have a long way to go to fulfill the potential economic
value of self-care. The GSCF launched the Self-Care Readiness Index 2.0, a
research and policymaking tool which explores the key enablers of self-care and
gives countries a score ranging from 1 (not self-care ready) to 4 (exceptionally
self-care ready). Colombia scored a 2.9 while India scored a 2.7; Indonesia a 2.73;
Kenya a 2.38; Mexico a 3.03; Singapore a 3.16; and UAE a 2.72. Improvements in
patient empowerment, self-care health policy, and the regulatory environment
will be necessary to bridge the gap between potential and real economic value
of self-care. The first and second edition of the Self-Care Readiness Index
have confirmed that Low- and Middle-Income Countries (LMICs) were more
likely to utilize multidisciplinary care teams and empower practitioners such
as pharmacists and community health workers to deliver care and educate
patients on self-care behaviors. This brings a vast array of opportunities for the
implementation of innovative patient engagement strategies to achieve better
health outcomes while improving the efficiency of public healthcare systems.
Increased regulatory reliance can help emerging market NRAs achieve Latin American NRAs are increasingly involved in regulatory
friendlier and more efficient regulatory pathways that increase the harmonization and reliance initiatives. For example, the Brazilian and
access to innovative treatments and interventions in geographies who Mexican regulatory agencies, ANVISA and COFEPRIS, are members of
are usually in the second and third waves of access. This increased access the International Council for Harmonization of Technical Requirements
can, in consequence, contribute to decreasing universal health coverage for Pharmaceuticals for Human Use (ICH). However, there is still a long
gaps. Regulatory harmonization can reduce the costs of regulatory road ahead to achieve a significant level of regulatory harmonization in
processes in already financially strained health systems. For example, Latin America and other emerging markets as regulatory pathways are
many emerging markets do not have a fast-track approval process for painfully heterogenous, complicating launch and access planning for
OTCs and low –risk medicines. This means that NRAs are using their global healthcare companies.
MORE EFFICIENT
REGULATORY
PATHWAYS CAN
IMPROVE THE ACCESS
TO INNOVATIVE
THERAPIES
LASTING consumers will be long seen in 2023 and beyond, with fundamental
changes occurring in healthcare dynamics in emerging markets. Several
years of massive increases in health budgets and the prioritization of
HEALTHCARE
Diabetes, mental health, and obesity are on the rise as the pandemic
ends. Governments will need to reconcile pandemic preparedness
and budgets for routine COVID-19 vaccination with the urgent need
DYNAMICS AND
to strengthen preventive care and reduce the burden of NCDs. In a
context of scarce fiscal space, emerging markets will need ample public-
private cooperation in this realm.
PATIENTS AFTER
THE PANDEMIC
The pandemic has also deeply shifted consumer behavior and their
relationship with their health. Now, most people are comfortable
performing an at-home COVID-19 test, which has resulted in more
acceptance and increased use of home-based tests for monitoring
The race to catch up on NCD diagnosis will present an opportunity for and informing health. This new ownership of health is set to continue
healthcare companies operating in emerging markets to collaborate and will lead patients to be more engaged with technology to manage
with central and local governments, academia and civil society while their health. This shift towards a point-of-care at home approach will
strengthening their local relationships and footprint. The pandemic present an opportunity for innovative diagnosis campaigns, especially
also catalyzed the use of telemedicine and other technological tools to for therapeutic areas where prevention results in significant value and
increase the availability of healthcare services. This brings a new array savings for the healthcare system like HPV. On the other hand, there will
of opportunities to improve patient journeys and leverage the renewed also be an increased need for investment in health literacy so consumers
interest in rethinking how technology can be used to promote access to can have a safe and effective digital health journey. For example,
healthcare in different settings, especially in low- and middle-income regulatory advances to allow for e-labelling and a safer e-commerce
countries that face significant coverage and accessibility challenges. ecosystem for prescription and over-the-counter medications.
According to estimates from the WHO by 2030 there will be a shortage healthcare. Increasingly, healthcare companies are offering payers
of approximately 18 million health professionals worldwide. This risk-sharing mechanisms based on financial or health outcomes
shortage combined with increasing healthcare costs and growing that can help healthcare systems with limited resources focus
populations across the world, call for a significant shift in how we deliver their budgets on innovative yet effective interventions. However,
healthcare. This will be a shift from in-person to digital, from services to to implement these mechanisms, healthcare providers need to
solutions and from treatment to prevention. Integrated care for NCDs invest in data management systems and know-how to effectively
will need to leverage available digital solutions and focus on preventing measure improvements in health outcomes. Furthermore, outdated
patients from needing costly treatments and procedures down the procurement provisions will need to be streamlined and modified to
road, while cancer care will need to integrate primary and specialized allow for performance-based contracting.
healthcare systems and invest in value-based financing mechanisms
amid limited fiscal space. Increasingly, healthcare companies will shift from having a product-
buyer relationship with payers to one of service delivery, with
The demand for digital health solutions will emerge from the new integrated management of NCDs presenting a significant opportunity
patient-centric, individualized, and preventive care approaches that for public-private collaboration. Local capacity building, strengthening
are driving the evolution of healthcare systems. One of the main of relationship with local health ecosystem and early engagement
drivers behind integrated care will be the digitalization of healthcare with payers and regulators will be essential for healthcare companies
delivery, particularly the integration of medical records and increased operating in emerging markets. There is also a need to expand
access to primary care. In emerging markets where healthcare systems relationship further to other sector to identify potential ways of
have fragmented coverage and specialists are concentrated in urban collaborating, specially to advance in digitalization & technology, as well
centers, telehealth can provide scalable primary healthcare services as to making healthcare processes more sustainable and committed to
nationwide and worldwide. However, implementing telehealth in climate change challenges ahead of us. Speyside’s offering of integrated
emerging markets faces challenges from technical, organizational, policy and corporate affairs advisory can help leading companies
and human perspectives. Governments and healthcare companies maximize their market entry and growth potential. The availability of
will need to invest in digital equity (in terms of technology access and expert consultants on the ground also makes Speyside an ideal partner
e-health literacy) to maximize the benefits of telehealth services to the to design and implement market access strategies that prepare the
populations in underserved areas. landscape for sustainable business results. Please visit our website for
more information.
Investment in data literacy among healthcare providers and the
robustness of health data will also be needed so emerging markets
can implement innovative contracting mechanisms and value-based